Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 18, 2022

Accession no.
0001209191-22-057939
Filed
Nov 18, 2022
Trade date
Sep 27-Oct 31, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 25 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.55K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2022Common StockPPurchaseAcquired+105$2.57+$269.85197,180Direct
Sep 28, 2022Common StockPPurchaseAcquired+105$2.52+$264.6197,285Direct
Sep 29, 2022Common StockPPurchaseAcquired+105$2.51+$263.55197,390Direct
Sep 30, 2022Common StockPPurchaseAcquired+105$2.61+$274.05197,495Direct
Oct 3, 2022Common StockPPurchaseAcquired+105$2.54+$266.7197,600Direct
Oct 4, 2022Common StockPPurchaseAcquired+105$2.61+$274.05197,705Direct
Oct 5, 2022Common StockPPurchaseAcquired+105$2.58+$270.9197,810Direct
Oct 6, 2022Common StockPPurchaseAcquired+105$2.65+$278.25197,915Direct
Oct 7, 2022Common StockPPurchaseAcquired+105$2.66+$279.3198,020Direct
Oct 10, 2022Common StockPPurchaseAcquired+105$2.53+$265.65198,125Direct
Oct 11, 2022Common StockPPurchaseAcquired+105$2.48+$260.4198,230Direct
Oct 12, 2022Common StockPPurchaseAcquired+105$2.49+$261.45198,335Direct
Oct 13, 2022Common StockPPurchaseAcquired+105$2.38+$249.9198,440Direct
Oct 14, 2022Common StockPPurchaseAcquired+105$2.31+$242.55198,545Direct
Oct 17, 2022Common StockPPurchaseAcquired+105$2.33+$244.65198,650Direct
Oct 18, 2022Common StockPPurchaseAcquired+105$2.46+$258.3198,755Direct
Oct 19, 2022Common StockPPurchaseAcquired+105$2.42+$254.1198,860Direct
Oct 20, 2022Common StockPPurchaseAcquired+105$2.44+$256.2198,965Direct
Oct 21, 2022Common StockPPurchaseAcquired+105$2.49+$261.45199,070Direct
Oct 24, 2022Common StockPPurchaseAcquired+105$2.38+$249.9199,175Direct
Oct 25, 2022Common StockPPurchaseAcquired+105$2.44+$256.2199,280Direct
Oct 26, 2022Common StockPPurchaseAcquired+105$2.42+$254.1199,385Direct
Oct 27, 2022Common StockPPurchaseAcquired+105$2.49+$261.45199,490Direct
Oct 28, 2022Common StockPPurchaseAcquired+105$2.52+$264.6199,595Direct
Oct 31, 2022Common StockPPurchaseAcquired+105$2.54+$266.7199,700Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)